-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
R-CHOP is the standard protocol for diffuse large B-cell lymphoma (DLBCL), but as with all anthracyclines, doxorubicin has dose-dependent cardiotoxicity, particularly in patients with congestive heart failure and in patients with previous exposure to
However, it is unethical to perform RCTs in patients who are not candidates for anthracycline therapy, as patients randomly assigned to the doxorubicin group experience severe cardiotoxicity due to their cardiac insufficiency and therefore tendance score matching
Research design
References
Diana Al-Sarayfi,et al.
: ,